Search

everythinglearnresearchcommunity

for

Search:↓

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Female pattern hair loss does not significantly affect sexual dysfunction.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

The document's conclusion cannot be provided because the content is not accessible or understandable.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Testosterone helps prevent skin damage in males by acting through both estrogen and androgen pathways.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Ethosomes are a promising method for treating hair loss by delivering drugs directly to the scalp.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Finasteride may lower cholesterol and slow heart disease progression.

Women with acne and PCOS should be checked for insulin resistance and related symptoms.

Hair becomes gray and thin as we age, and while most hair loss in older people is due to genetics, there's a chance for gray hair to regain color under certain conditions.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Applying DMG-Na to the skin increases blood flow and may help with skin conditions.

Classical PCOS types A and B are most common and linked to higher health risks.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.